SIRT2 as a new player in epigenetic programming of keratinocyte differentiation and a candidate tumor suppressor

E-ISSN： 1600-0625|23|9|636-638

ISSN： 0906-6705

Source： EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol.23, Iss.9, 2014-09, pp. : 636-638

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mammalian SIRT2 inhibits keratin 19 expression and is a tumor suppressor in skin

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 23, Iss. 3, 2014-03 ,pp. : 207-209

John Wiley & Sons Inc

Access to resources Recommend Favorite

miRNA-205 Is a Candidate Tumor Suppressor that Targets ZEB2 in Renal Cell Carcinoma

Oncology Research and Treatment, Vol. 37, Iss. 11, 2014-10 ,pp. : 658-664

Karger

Access to resources Recommend Favorite

Epigenetic silencing of CHD5, a novel tumor‐suppressor gene, occurs in early colorectal cancer stages

CANCER, Vol. 120, Iss. 2, 2014-01 ,pp. : 172-180

John Wiley & Sons Inc

Access to resources Recommend Favorite

Re‐expression of Lactotransferrin, a candidate tumor suppressor inactivated by promoter hypermethylation, impairs the malignance of oral squamous cell carcinoma cells.

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 8, 2015-09 ,pp. : 578-584

John Wiley & Sons Inc

Access to resources Recommend Favorite

When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene

By Chow Amy

Journal of Mammary Gland Biology and Neoplasia, Vol. 16, Iss. 2, 2011-06 ,pp. : 81-88

Springer Publishing Company

Access to resources Recommend Favorite